Vigamox Treatment for Ocular Graft-Versus-Host Disease

Summary

In this study the investigators seek to prospectively measure the response of ocular graft-versus-host disease (GVHD) patients to treatment with topical Vigamox. The investigators will accomplish this by enrolling patients with bilateral ocular GVHD and treating one eye with topical Vigamox and the other eye with a placebo eye drop. By assessing the response to treatment with Vigamox, the investigators hope to identify a role for topical antibiotic treatment in ocular GVHD.

Timeline

Start

2020-06-15

Primary completion

2025-03-31

Completion

2025-03-31

Drugs

Indications